5 min. read
In this discussion, industry experts delve into the complexities of PMTA approvals and the impact of FDA regulations on the tobacco and nicotine sectors. They highlight the importance of innovation, the need for comprehensive scientific data, and the challenges posed by shifting regulatory landscapes. Discover how professionals are advocating for more consistent tools and guidance to ensure industry survival and public health. Read More
3 min. read
Understanding the regulatory landscapes of both the nicotine and cannabis industries is paramount for any business operating within these sectors. In this speech, we will explore the parallels between the nicotine and cannabis spaces, drawing on valuable lessons learned from the nicotine industry that can be effectively applied to the burgeoning cannabis market. Read More
1 min. read
By Scott Appleton , Helen Cyrus‑Miller, Ryan Seltzer, Karin Gilligan and Willie McKinney Abstract: Inaccurate labels on some e-cigarette products […] Read More
7 min. read
By Willie McKinney and Cheryl K. Olson Let’s do a thought experiment. Imagine–some of this may sound familiar–that you’re one […] Read More
7 min. read
By Cheryl K. Olson, Sc.D. – Reshared from the February 2021 edition of the Tobacco Reporter In October 2020, the […] Read More
1 min. read
We will be sharing scientific information at the upcoming Society for Research on Nicotine and Tobacco (SRNT) Conference on February […] Read More
4 min. read
by Cheryl K. Olson, Sc.D. TPPI studies are studies that can be used to assess, among other things, individuals’ perceptions […] Read More
3 min. read
by Cheryl K. Olson, Sc.D. Cigarettes used to be the most-accessible for experimentation. In many places, it’s now e-cigarettes or […] Read More
4 min. read
by Willie McKinney, Ph.D., DABT Looking ahead after the PMTA submission deadline Although it’s well outside of their purview, the […] Read More
"*" indicates required fields